Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 348

Parkwalk shifts return in Animal Dynamics

Parkwalk Advisors has sold on most of its stake in Oxford-founded drone designer Animal Dynamics, securing a 6.9 times return.

Mar 14, 2019

Sage steps up to partner at BMW i Ventures

Kasper Sage, a former BMW i Ventures principal featured on this year's GCV Rising Stars roster, was named partner at the beginning of this year.

Mar 14, 2019

Jumia to jump to public markets

The Africa-focused e-commerce platform, backed by MTN, Rocket Internet, Millicom, Orange, Axa and Pernod Ricard, has filed for a $100m initial public offering in the US.

Mar 13, 2019

Pagantis pages investors for $75m

Credit Suisse-backed SPF Investment Management has contributed to a $75m series B round for Pagantis, the online lender previously known as Digital Origin.

Mar 12, 2019

Snipr hits funding target to raise $50m

Founding investor Lundbeckfonden Emerge returned to co-lead a series A round for the gene editing drug developer with Life Science Partners.

Mar 12, 2019

10x goes Nationwide for series B funding

Natiowide has taken a minority stake in financial services portal developer 10x Future Technologies through a $16.9m series B investment.

Mar 12, 2019

JLL picks Concrete to source proptech investments

JLL Spark's $100m Global Venture Fund has appointed Concrete VC to source real estate technology investment opportunities in the EMEA region.

Mar 12, 2019

PolyAI understands $12m series A

The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.

Mar 11, 2019

CIC turns up for Gyroscope

Gyroscope Therapeutics recently commenced phase 1/2 clinical trials on a retinal gene therapy for dry age-related macular degeneration.

Mar 11, 2019

Big deal: Anaveon proves UZH fund model works

Anaveon emerged out of University of Zurich in late 2017 with the support of Novartis-backed UZH Life Sciences Fund and the corporate has now also invested directly.

Mar 11, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here